Portsmouth, NH, April, 26th 2017 – MMIS President and CEO Michaeline Daboul will be speaking at CBI’s 14th Annual Pharmaceutical Compliance Congress, in Washington, D.C. on April 26-28. “First generation aggregate spend systems were designed in a reactive manner based upon the state and federal reporting requirements”, commented Ms. Daboul. “As governments continue to enforce anti-kickback laws and with the introduction of global data privacy regulations, it is critically important for manufacturers to now focus on their upstream processes to improve their overall compliance programs and reporting capabilities.”

Ms. Daboul, is scheduled to lead a session titled: Building the Next Generation Global Transparency Program – A Case Based Roadmap to Improve Compliance – Gain Efficiencies – Demonstrate Value on Thursday, April 27th at 2:35 pm. As an industry expert, she will be speaking on how life science companies are adopting cloud-based compliance platforms to improve their upstream processes and downstream reporting capabilities. Using a case-based approach, she will highlight:

  • How anti-kickback and global data privacy laws should drive increased attention to upstream compliance processes and systems;
  • New standards and best practices for HCE engagement and streamlined enterprise compliance management to ensure adherence with global laws, industry codes, and company policies;
  • Strategies to assess current processes, enabling technologies, and internal compliance monitoring programs to drive change towards cloud compliance; and
  • Opportunities to leverage or replace legacy systems, demonstrate savings through process improvement, and value through real-time analysis and monitoring.

MediSpend (www.medispend.com) is the first secure end-to-end software-as-a-service (SaaS) global compliance cloud solution designed specifically to help pharmaceutical and medical device companies manage health care entity (HCE) interactions, track and report HCE spend, and monitor and analyze compliance programs.

Ms. Daboul has been interviewed by Inside CMS, CIO Review, Healthcare Finance News, Mass Device and Healthcare Review North East Network on compliance challenges and the importance of implementing a global compliance process. CBI’s 14th Annual Pharmaceutical Compliance Congress offers the opportunity for life sciences companies to come together, share ideas, network and learn from one another. 


Recognized by CIO Review in 2015 and 2016 for its annual listing of the 20 Most Promising Pharma and Life Science Technology Solution Providers, MMIS continues to break new ground with the first end-to-end compliance and data analytics SaaS solution, benefiting its customers around the globe.

For more information and to request a demo of the MediSpend Global Compliance Solutions, please visit www.medispend.com.

About MMIS

MMIS, Inc. is the industry leader in cloud-based compliance software for the global life sciences industry and the creator of the MediSpend® Compliance Cloud.  We are committed to customer success, developing innovative products and helping our customers comply with global healthcare laws and regulations.

MediSpend® customers range from the world’s largest medical device, pharmaceutical and dental companies to emerging companies. Our customers are located in the U.S., Europe, Asia, and Latin America. For more information, visit www.medispend.com.